Becton, Dickinson and Company (BDX): A Bull Case Theory 

We came across a bullish thesis on Becton, Dickinson and Company on Value Don’t Lie’s Substack. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company’s share was trading at $201.09 as of January 29th. BDX’s trailing and forward P/E were 34.55 and 13.44 respectively according to Yahoo Finance.

Astera Labs (ALAB) Declines 13% on Profit-Taking

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare...